Prothena Corporation PLC (NASDAQ:PRTA)

9.87
Delayed Data
As of Jul 22
 +0.01 / +0.10%
Today’s Change
8.63
Today|||52-Week Range
15.91
-4.17%
Year-to-Date

Today’s Trading

Previous close9.86
Today’s open9.89
Day’s range9.77 - 10.02
Volume94,252
Average volume (3 months)273,695
Market cap$393.1M
Data as of 4:00pm ET, 07/22/2019

Growth & Valuation

Earnings growth (last year)+3.33%
Earnings growth (this year)+42.79%
Earnings growth (next 5 years)-6.99%
Revenue growth (last year)-96.53%
P/E ratioNM
Price/Sales426.66
Price/Book1.22

Competitors

 Today’s
change
Today’s
% change
PRVLPrevail Therapeutics...+0.56+4.81%
SRRKScholar Rock Holding...-0.42-3.19%
MITOStealth BioTherapeut...+0.17+1.50%
REPLReplimune Group Inc+0.23+1.90%
Data as of 4:00pm ET, 07/22/2019

Financials

Next reporting dateAugust 5, 2019
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$955.0K
Annual profit (last year)-$155.6M
Net profit margin-16,297.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gene G. Kinney
Chief Operating &
Financial Officer
Tran B. Nguyen
Corporate headquarters
Dun Laoghaire, Dublin

Forecasts